Urinary incontinence in women

Medical Clinics of North America

Volumn 95, Issue 1, 2011, Pages 101-109

  Deng, Donna Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Overactive bladder; Stress incontinence; Urge incontinence; Urgency; Urinary frequency

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN A; CAFFEINE; CARBON; CHOLINERGIC RECEPTOR BLOCKING AGENT; COLLAGEN; DARIFENACIN; DIMETICONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DULOXETINE; HYDROXYAPATITE; HYOSCYAMINE; IMIPRAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SOLIFENACIN; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; TROSPIUM CHLORIDE;

AGING; AMNESIA; ATTENTION DEFICIT DISORDER; BLADDER SPHINCTER; CHILDBIRTH; CLINICAL PRACTICE; COGNITIVE DEFECT; COMORBIDITY; CONSERVATIVE TREATMENT; COUGHING; DETRUSOR MUSCLE; DEVICE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; FEEDBACK SYSTEM; FEMALE; FLUID INTAKE; HEART PALPITATION; HUMAN; LIFESTYLE MODIFICATION; LIVER TOXICITY; MENOPAUSE; NERVE STIMULATION; NEUROLOGIC DISEASE; OBESITY; OVERACTIVE BLADDER; PATIENT EDUCATION; PELVIC FLOOR MUSCLE TRAINING; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRACTICE GUIDELINE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; STRESS INCONTINENCE; SUICIDAL BEHAVIOR; TACHYCARDIA; URETHRAL SLING; URGE INCONTINENCE; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; URINE INCONTINENCE; URINE RETENTION; URODYNAMICS; UROLOGIC SURGERY; WEIGHT REDUCTION; WOMEN'S HEALTH;

AGE FACTORS; FEMALE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; PRIMARY HEALTH CARE; RISK FACTORS; URINARY INCONTINENCE; URINARY INCONTINENCE, STRESS; URINARY INCONTINENCE, URGE;

EID: 78649349956     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.08.022     Document Type: Review

References (5)

1. Abrams P., Cardozo L., Fall M., et al. The standardization of terminology of lower urinary tract function: report from the Standadisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002, 21:167-178.
2. Stewart W.F., Van Rooyen J.B., Cundiff G.W., et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003, 20(6):327-336.
3. Resnick N.M. Geriatric incontinence. Urol Clin North Am 1996, 23(1):55-75.
4. Burgio K.L., Locher J.L., Goode P.S., et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA 1998, 280:1995-2000.
5. Karsenty G., Denys P., Amarenco G., et al. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol 2008, 53(2):275-287.